HANDIPLASMID
Live / Registered — Registered (as of 05 Nov 2024)
What this means for you
Registered since 05 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98044790
- Registration number
- 7560866
- Mark type
- Design + words
- Filed
- 15 Jun 2023
- Published for opposition
- 05 Dec 2023
- Registered
- 05 Nov 2024
- Attorney of record
- Michael T. Smith
Goods and services
- Class 042 — Scientific and technological services: Developing new products for others; development of biological medicines; scientific research and development; antibody drug, mRNA vaccine medicine research; research and development of new products; consulting services in the field of technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies
Owner
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, CO LOUTH, IE
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, CO LOUTH, IE
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, CO LOUTH, IE
Prosecution history
- 05 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 22 May 2024 — USE AMENDMENT FILED
- 29 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 30 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Dec 2023 — PUBLISHED FOR OPPOSITION
- 15 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE